Granules India informs about company updates

27 May 2019 Evaluate

Granules India has informed that Granules Pharmaceuticals, Inc. received US FDA approval for Methylphenidate Hydrochloride Extended-Release capsules.

The above information is a part of company’s filings submitted to BSE.

Granules India Share Price

566.00 4.30 (0.77%)
16-Mar-2026 14:54 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1790.85
Dr. Reddys Lab 1280.10
Cipla 1303.00
Zydus Lifesciences 891.80
Lupin 2302.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×